Serial Number | 90221395 |
Word Mark | DIZAL |
Filing Date | Tuesday, September 29, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, November 1, 2022 |
Registration Number | 6890229 |
Registration Date | Tuesday, November 1, 2022 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, January 4, 2022 |
Description of Mark | The mark consists of the wording "DIZAL" above four Chinese Characters. To the left of the wording is a design of two curved bands. |
Goods and Services | Preparations for destroying noxious animals; antiseptics; bacterial culture mediums; bouillons for bacteriological cultures; media for bacteriological cultures; bacterial poisons; balsamic preparations for medical purposes; insecticides; medicinal preparations for the mouth to be applied in the form of capsules; pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; chemico-pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; collyrium; medicines for alleviating constipation; solutions for contact lenses; radiological contrast substances for medical purposes; depuratives for the body; digestives for pharmaceutical purposes; analgesics; drugs for medical purposes for treatment of human illnesses, namely, anti-tumor treatment; filled portable medicine cases, comprised of pharmaceuticals for treatment of human illnesses, namely, anti-tumor treatment; pharmaceutical preparations, namely, elixirs for anti-tumor treatment; mineral, bath and sodium salts for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; fungicides; gelatine for medical purposes, namely, gelatin capsules sold empty; germicides; chewing gum for medical purposes; medicated lozenges for pharmaceutical purposes; cough pastilles for pharmaceutical purposes; rat poison; antibiotic, sunburn and anti-inflammatory ointments for pharmaceutical purposes; organotherapy preparations; opotherapy preparations; pharmaceutical preparations for skin care; herbal teas for medicinal purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; first-aid boxes, filled; blood plasma; radioactive substances for medical purposes; tonics being pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; blood for medical purposes; sterilizing preparations; styptic preparations; aluminum acetates for pharmaceutical purposes; acids for pharmaceutical purposes; dietetic foods adapted for medical purposes; biological preparations for medical purposes for treatment of human illnesses; dietetic beverages adapted for medical purposes; crystallized rock sugar for medical purposes; candy for medical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; by-products of the processing of cereals for dietetic or medical purposes; chemical preparations for pharmaceutical purposes for the treatment of human illnesses, namely, anti-tumor treatment; medicines for dental purposes; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; diagnostic preparations for medical purposes; medicinal drinks; petroleum jelly for medical purposes; isotopes for medical purposes; dietetic substances of low sugar and salt adapted for medical use; chemical preparations as medicines for medical purposes, namely, for anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; contact lens cleaning preparations; enzymes for medical purposes; enzyme preparations for medical purposes; amino acids for medical purposes; antibiotics; bronchodilating preparations; medicinal hair growth preparations; adjuvants for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; medicated eye-washes; antioxidant pills for medical use; protein dietary supplements; reagent paper for medical purposes; pesticides; diagnostic biomarker reagents for medical purposes; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposes, namely, anti-tumor treatment; reagent paper for veterinary purposes; astringents for medical purposes; insecticidal veterinary washes; capsules made of dendrimer-based polymers for medicinal preparations for the mouth, for pharmaceuticals purposes; raw material drugs, namely, pharmaceuticals for anti-tumor treatment; Chinese medicine nostrum for the treatment of tumors in humans; pharmaceutical blood preparations, namely, a blood clotting aid and delivery system for use in human medicine; rubbing alcohol; agricultural fungicide; eye drops; insect killing preparations in the nature of pesticides; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; candy for pharmaceutical purpose for treatment of the cough; bacteriological research preparation, namely, preparations of reports for anti-tumor treatment for medical purposes; bacterial preparations for medical purposes for researching of human illnesses; medical probiotic supplements; medical diagnosis reagent; vaccine preparations; contact lenses care solution; contact lens disinfectant; biological agents for the treatment of cancer |
Goods and Services | Publicity consultation and agency services in the field of medicines; provision of goods sales information, namely, sales information about goods for anti-tumor treatment; retail store services featuring pharmaceutical, sanitary preparations and medical supplies; wholesale distributorships featuring pharmaceutical preparations, sanitary preparations, and medical supplies; retail store services and wholesale store services featuring pharmaceutical drugs; retail store services and wholesale store services featuring medicinal preparations; retail store services and wholesale store services featuring sanitary preparations; retail store services and wholesale store services featuring medical supplies |
Transliteration Statement | The non-Latin characters in the mark transliterate to "DI", "ZHE", "DI ZHE", "YI", "YAO" and "YI YAO" and this means "Enlightenment", "Philosophy", "Medical", "Medicine" and "Pharmaceutical" in English. |
Disclaimer with Predetermined Text | THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "YI YAO" |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 12, 2020 |
Primary Code | 005 |
First Use Anywhere Date | Friday, October 27, 2017 |
First Use In Commerce Date | Monday, November 18, 2019 |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 12, 2020 |
Primary Code | 035 |
First Use Anywhere Date | Friday, October 27, 2017 |
First Use In Commerce Date | Monday, November 18, 2019 |
Party Name | Dizal (Jiangsu) Pharmaceutical Co., Ltd |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Wuxi City, Jiangsu N/A CN |
Party Name | Dizal (Jiangsu) Pharmaceutical Co., Ltd |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Wuxi City, Jiangsu N/A CN |
Party Name | Dizal (Jiangsu) Pharmaceutical Co., Ltd |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Wuxi City, Jiangsu N/A CN |
Event Date | Event Description |
Tuesday, November 1, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, November 1, 2022 | REGISTERED-PRINCIPAL REGISTER |
Friday, September 30, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Wednesday, September 28, 2022 | ELECTRONIC RECORD REVIEW COMPLETE |
Friday, September 23, 2022 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
Tuesday, September 20, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Sunday, September 18, 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Friday, September 16, 2022 | STATEMENT OF USE PROCESSING COMPLETE |
Wednesday, August 31, 2022 | USE AMENDMENT FILED |
Wednesday, September 14, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, August 31, 2022 | TEAS STATEMENT OF USE RECEIVED |
Tuesday, March 1, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, January 4, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 4, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, December 15, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, November 24, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, November 22, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, November 22, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, November 22, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, October 14, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, October 14, 2021 | NON-FINAL ACTION E-MAILED |
Thursday, October 14, 2021 | NON-FINAL ACTION WRITTEN |
Tuesday, October 12, 2021 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Tuesday, October 5, 2021 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Thursday, September 16, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Saturday, September 11, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, September 10, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, September 10, 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Friday, September 3, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Friday, September 3, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, September 3, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Friday, September 3, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, September 3, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, September 3, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Friday, March 12, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Friday, March 12, 2021 | FINAL REFUSAL E-MAILED |
Friday, March 12, 2021 | FINAL REFUSAL WRITTEN |
Wednesday, March 3, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, March 2, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, March 2, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, March 1, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, March 1, 2021 | NON-FINAL ACTION E-MAILED |
Monday, March 1, 2021 | NON-FINAL ACTION WRITTEN |
Monday, February 22, 2021 | ASSIGNED TO EXAMINER |
Friday, November 13, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Thursday, November 12, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Friday, October 2, 2020 | NEW APPLICATION ENTERED IN TRAM |